{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T22:40:07Z","timestamp":1696977607612},"reference-count":58,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2005,11,16]],"date-time":"2005-11-16T00:00:00Z","timestamp":1132099200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Academy of Nurse Practitioners"],"published-print":{"date-parts":[[2005,12]]},"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>The purpose of this paper is to review (a) the linkage between the BRCA1 gene and ovarian cancer and (b) BRCA1 testing and its related issues. This review is aimed for nurse practitioners (NPs), who may be in positions to identify those at risk for BRCA1\u2010associated ovarian cancer and to assist patients with related issues.<\/jats:p><\/jats:sec><jats:sec><jats:title>Data sources<\/jats:title><jats:p>Data sources include reviews and original research from scholarly journals and Internet sites.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Ovarian cancer is a deadly disease. Identification of those at risk because of BRCA1 mutation is possible through genetic testing. Testing for BRCA1 gene mutations has many implications whether results are positive or negative. Those with positive results will be faced with decisions regarding the best management strategies. Negative results do not completely eliminate ovarian cancer risk. Current management options for carriers of the BRCA1 mutation include taking no action, increasing surveillance for ovarian cancer, and chemoprevention with oral contraceptives or prophylactic oophorectomy for those who have completed childbearing. It is essential that NPs have knowledge underlying the issues and concerns of patients and their families at risk for BRCA1\u2010associated ovarian cancer.<\/jats:p><\/jats:sec><jats:sec><jats:title>Implications for practice<\/jats:title><jats:p>NPs are in a unique position to help identify BRCA1 mutation carriers and to assist them and their families with the complex issues involving genetic testing and management options. Understanding these issues will allow NPs to give appropriate care that may include making appropriate referrals to certified genetic counselors and having balanced discussions on treatment options. Such measurements may improve early diagnosis of ovarian cancer and increase survival from this disease.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1745-7599.2005.00091.x","type":"journal-article","created":{"date-parts":[[2005,11,16]],"date-time":"2005-11-16T22:19:58Z","timestamp":1132179598000},"page":"518-526","source":"Crossref","is-referenced-by-count":5,"title":["BRCA1 Genetic Mutation and Its Link to Ovarian Cancer: Implications for Advanced Practice Nurses"],"prefix":"10.1111","volume":"17","author":[{"given":"Amy N.","family":"Brunsvold","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu\u2010Fen","family":"Wung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carrie J.","family":"Merkle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,11,16]]},"reference":[{"key":"e_1_2_8_2_1","unstructured":"American Cancer Society. (2003).Facts and figures. Retrieved March 29 2005 fromhttp:\/\/www.cancer.org\/docroot\/CRI\/content\/CRI_2_4_3X_Can_ovarian_cancer_be_found_early_33.asp"},{"key":"e_1_2_8_3_1","unstructured":"American Cancer Society. (2005a).Detailed guide: Ovarian cancer. How is ovarian cancer staged?Retrieved March 29 2005 fromhttp:\/\/www.cancer.org\/docroot\/CRI\/content\/CRI_2_4_3X_how_is_ovarian_cancer_staged_33.asp?sitearea=CRI"},{"key":"e_1_2_8_4_1","unstructured":"American Cancer Society. (2005b).Overview: Ovarian cancer. How many women get ovarian cancer. Retrieved March 29 2005 fromhttp:\/\/www.cancer.org\/downloads\/stt\/Leading_Sites_of_New_Cancer_Cases_and_Deaths___2005_Estimates.pdf"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1086\/375033"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200002243420807"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1006\/pmed.2002.1022"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20010715)92:2<440::AID-CNCR1340>3.0.CO;2-O"},{"issue":"3","key":"e_1_2_8_9_1","first-page":"745","article-title":"Recommendations for standardized human pedigree nomenclature. Pedigree standardization task force of the national society of genetic counselors","volume":"56","author":"Bennett R. L.","year":"1995","journal-title":"American Journal of Human Genetics"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/pon.653"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1997.03540360065034"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-0004.1999.550605.x"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.08.147"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.8.2357"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.279.12.955"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(00)00849-8"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.2000.5983"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)91578-4"},{"issue":"2","key":"e_1_2_8_19_1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/milmed\/167.2.99","article-title":"Diagnostic criteria for testing for BRCA1 and BRCA2: The experience of the Department of Defense Familial Breast\/Ovarian Cancer Research Project","volume":"167","author":"Fries M. H.","year":"2002","journal-title":"Military Medicine"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/pon.512"},{"issue":"5","key":"e_1_2_8_21_1","first-page":"1239","article-title":"Frequently occurring germ\u2010line mutations of the BRCA1 gene in ovarian cancer families from Russia","volume":"60","author":"Gayther S. A.","year":"1997","journal-title":"American Journal of Human Genetics"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20001115)89:10<2068::AID-CNCR6>3.0.CO;2-Z"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1086\/302922"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.10.101"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMed020044"},{"issue":"5","key":"e_1_2_8_26_1","first-page":"41","article-title":"Knowledge essential to ovarian cancer care","volume":"96","author":"Haley S","year":"2000","journal-title":"Nursing Times"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/1099-1611(200011\/12)9:6<486::AID-PON478>3.0.CO;2-Y"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1547-5069.2005.00007.x"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/93.21.1633"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)10261-1"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020119"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)11087-7"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.13.1671"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1188\/03.ONF.927-933"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.3.334"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6690235"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.05.096"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-2115(98)00219-X"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.12.2484"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1002\/1099-1611(200011\/12)9:6<496::AID-PON487>3.0.CO;2-Z"},{"issue":"9","key":"e_1_2_8_41_1","first-page":"1535","article-title":"Role of tumour markers in monitoring epithelial ovarian cancer","volume":"82","author":"Meyer T.","year":"2000","journal-title":"British Journal of Cancer"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200107263450401"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199808133390702"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04642-0"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/91.17.1459"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000446-200212000-00015"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)90078-8"},{"issue":"1","key":"e_1_2_8_48_1","first-page":"79","article-title":"Health insurance and discrimination concerns and BRCA1\/2 testing in a clinic population","volume":"11","author":"Peterson E. A.","year":"2002","journal-title":"Cancer Epidemiology, Biomarkers and Prevention"},{"issue":"4","key":"e_1_2_8_49_1","first-page":"868","article-title":"Survival in familial, BRCA1\u2010associated, and BRCA2\u2010associated epithelial ovarian cancer. United Kingdom Coordinating Committee for Cancer Research (UKCCCR) Familial Ovarian Cancer Study Group","volume":"59","author":"Pharoah P. D.","year":"1999","journal-title":"Cancer Research"},{"issue":"12","key":"e_1_2_8_50_1","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.5858\/2002-126-1518-PATTMD","article-title":"Proteomic approaches to tumor marker discovery","volume":"126","author":"Rai A. J.","year":"2002","journal-title":"Archives of Pathology and Laboratory Medicine"},{"key":"e_1_2_8_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(02)00269-1"},{"key":"e_1_2_8_52_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1998.00577.x"},{"key":"e_1_2_8_53_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/95.14.1072"},{"key":"e_1_2_8_54_1","volume-title":"Widmann's clinical interpretation of laboratory tests","author":"Sacher R. A.","year":"2000"},{"key":"e_1_2_8_55_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1998.tb10148.x"},{"key":"e_1_2_8_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(03)00123-6"},{"key":"e_1_2_8_57_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1552-6909.2002.tb00038.x"},{"key":"e_1_2_8_58_1","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.2000.5816"},{"key":"e_1_2_8_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80936-8"}],"container-title":["Journal of the American Academy of Nurse Practitioners"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1745-7599.2005.00091.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1745-7599.2005.00091.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T22:14:03Z","timestamp":1696976043000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1745-7599.2005.00091.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11,16]]},"references-count":58,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["10.1111\/j.1745-7599.2005.00091.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1745-7599.2005.00091.x","archive":["Portico"],"relation":{},"ISSN":["1041-2972","1745-7599"],"issn-type":[{"value":"1041-2972","type":"print"},{"value":"1745-7599","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11,16]]}}}